Ling-Yi Kong (Lingyi Kong)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 7

Top Topics

Molecular Dynamics Simulations

Structure Activity Relationship

Combination Therapy

Top Venues

Chemical communications (Cambridge, England)

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Wen-Li Wang, Xiao-Qin Liu, Mei-Hui Zhang, Bin Lin, Dong-Rong Zhu, Ling-Nan Li, Chen Chen, Chao Han, Jian-Guang Luo, Ling-Yi Kong
Taxodisones A and B: bioactive C30-terpenes with new skeletons from Taxodium distichum and their biosynthetic origin. Chemical communications (Cambridge, England) 56 (22) (2020)
Xiao-Bing Wang, Fu-Cheng Yin, Ming Huang, Neng Jiang, Jin-Shuai Lan, Ling-Yi Kong
Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease. RSC medicinal chemistry 11 (2) (2020)
Hong Zhang, Ming-Hua Yang, Fang-Fang Zhuo, Na Gao, Xiao-Bei Cheng, Xiao-Bing Wang, Yue-Hu Pei, Ling-Yi Kong
Seven new cytotoxic phenylspirodrimane derivatives from the endophytic fungus Stachybotrys chartarum . RSC advances 9 (7) (2019)
Tianyu Zhu, Chen Chen, Sisi Wang, Yi Zhang, Dongrong Zhu, Lingnan Li, Jianguang Luo, Ling-Yi Kong
Cellular target identification of Withangulatin A using fluorescent analogues and subsequent chemical proteomics. Chemical communications (Cambridge, England) 55 (57) (2019)
Jiawen Zhu, Jingting Chen, Dongmei Song, Wenda Zhang, Jianpeng Guo, Guiping Cai, Yuhao Ren, Chengying Wan, Ling-Yi Kong, Wenying Yu
Real-time monitoring of etoposide prodrug activated by hydrogen peroxide with improved safety. Journal of materials chemistry. B 7 (47) (2019)
Dong-Mei Sun, Fa-Liang An, Shan-Shan Wei, Yan-Qiu Zhang, Xiao-Bing Wang, Jun Luo, Ling-Yi Kong
Cipadessains A-K, eleven limonoids from the fruits of Cipadessa cinerascens . RSC advances 8 (19) (2018)
Qiao-Hong Liu, Jia-Jia Wu, Fan Li, Pei Cai, Xue-Lian Yang, Ling-Yi Kong, Xiao-Bing Wang
Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease. MedChemComm 8 (7) (2017)